BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 37834120)

  • 1. Estrogens, Estrogen Receptors and Tumor Microenvironment in Ovarian Cancer.
    Kozieł MJ; Piastowska-Ciesielska AW
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Crowded Crosstalk between Cancer Cells and Stromal Microenvironment in Gynecological Malignancies: Biological Pathways and Therapeutic Implication.
    De Nola R; Menga A; Castegna A; Loizzi V; Ranieri G; Cicinelli E; Cormio G
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogens and epithelial ovarian cancer.
    Cunat S; Hoffmann P; Pujol P
    Gynecol Oncol; 2004 Jul; 94(1):25-32. PubMed ID: 15262115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of steroid hormones, estrogen and progesterone, on epithelial mesenchymal transition in ovarian cancer development.
    Jeon SY; Hwang KA; Choi KC
    J Steroid Biochem Mol Biol; 2016 Apr; 158():1-8. PubMed ID: 26873134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epithelial-mesenchymal transition and the estrogen-signaling in ovarian cancer.
    Gallo D; Ferlini C; Scambia G
    Curr Drug Targets; 2010 Apr; 11(4):474-81. PubMed ID: 20015012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].
    Rochefort H
    C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of the Estrogen Pathway in the Tumor Microenvironment.
    Rothenberger NJ; Somasundaram A; Stabile LP
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feedback control of the CXCR7/CXCL11 chemokine axis by estrogen receptor α in ovarian cancer.
    Benhadjeba S; Edjekouane L; Sauvé K; Carmona E; Tremblay A
    Mol Oncol; 2018 Oct; 12(10):1689-1705. PubMed ID: 30051594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genistein suppressed epithelial-mesenchymal transition and migration efficacies of BG-1 ovarian cancer cells activated by estrogenic chemicals via estrogen receptor pathway and downregulation of TGF-β signaling pathway.
    Kim YS; Choi KC; Hwang KA
    Phytomedicine; 2015 Oct; 22(11):993-9. PubMed ID: 26407941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with the pure anti-estrogen fulvestrant durably remodels estrogen signaling in BG-1 ovarian cancer cells.
    Badia E; Docquier A; Busson M; Lapierre M; Pujol P; Balaguer P; Cavailles V
    J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):176-85. PubMed ID: 22652558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights on the role of hormonal therapy in ovarian cancer.
    Simpkins F; Garcia-Soto A; Slingerland J
    Steroids; 2013 Jun; 78(6):530-7. PubMed ID: 23402742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers.
    Ciucci A; Zannoni GF; Buttarelli M; Lisi L; Travaglia D; Martinelli E; Scambia G; Gallo D
    Oncotarget; 2016 Feb; 7(7):8155-71. PubMed ID: 26797759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Cell-Free Expression of MiR200 Family Members Correlates with Estrogen Sensitivity in Human Epithelial Ovarian Cells.
    Márton É; Varga A; Széles L; Göczi L; Penyige A; Nagy B; Szilágyi M
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33419253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of benzophenone-1 and octylphenol on the regulation of epithelial-mesenchymal transition via an estrogen receptor-dependent pathway in estrogen receptor expressing ovarian cancer cells.
    Shin S; Go RE; Kim CW; Hwang KA; Nam KH; Choi KC
    Food Chem Toxicol; 2016 Jul; 93():58-65. PubMed ID: 27145024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
    Carruba G
    J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The action of estrogens and progestogens in the young female breast.
    Zolfaroli I; Tarín JJ; Cano A
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():204-207. PubMed ID: 29627127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-genomic estrogen/estrogen receptor α promotes cellular malignancy of immature ovarian teratoma in vitro.
    Hung YC; Chang WC; Chen LM; Chang YY; Wu LY; Chung WM; Lin TY; Chen LC; Ma WL
    J Cell Physiol; 2014 Jun; 229(6):752-61. PubMed ID: 24142535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Tumor Microenvironment in Breast Cancer and the Participation of Estrogen and Its Receptors in Cancer Physiopathology.
    Segovia-Mendoza M; Morales-Montor J
    Front Immunol; 2019; 10():348. PubMed ID: 30881360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A hormonal impact on DMBA-induced rat ovarian cancer--detection of estrogen receptors, and resultant morphologic changes after estrogen application].
    Katabuchi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Sep; 35(9):1634-40. PubMed ID: 6413623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and function of androgen receptor coactivator p44/Mep50/WDR77 in ovarian cancer.
    Ligr M; Patwa RR; Daniels G; Pan L; Wu X; Li Y; Tian L; Wang Z; Xu R; Wu J; Chen F; Liu J; Wei JJ; Lee P
    PLoS One; 2011; 6(10):e26250. PubMed ID: 22022581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.